AKT1 and cancer: Also, the protection and further activation of Akt, a known substrate of Hsp90, in a response to chemotherapy is well established to confer the acquired drug resistance of cancer cells [179]; similarly, the stabilization of the Raf kinase may result in the enhanced activation of the Raf/MEK/ERK pathway, which can govern drug resistance [180].